The neuropathological hallmark of MSA is the presence of glial cytoplasmic inclusions (GCIs) containing α-synuclein; given this characteristic, MSA can be regarded as a synucleinopathy, together with PD and Lewy body dementia (DLB)26–28. This evidence concerns the gene SNCA and synucleinopathy.